Document Detail

Brain tumors.
MedLine Citation:
PMID:  23026359     Owner:  NLM     Status:  MEDLINE    
This review addresses the specific contributions of nuclear medicine techniques, and especially positron emission tomography (PET), for diagnosis and management of brain tumors. (18)F-Fluorodeoxyglucose PET has particular strengths in predicting prognosis and differentiating cerebral lymphoma from nonmalignant lesions. Amino acid tracers including (11)C-methionine, (18)F-fluoroethyltyrosine, and (18)F-L-3,4-dihydroxyphenylalanine provide high sensitivity, which is most useful for detecting recurrent or residual gliomas, including most low-grade gliomas. They also play an increasing role for planning and monitoring of therapy. (18)F-fluorothymidine can only be used in tumors with absent or broken blood-brain barrier and has potential for tumor grading and monitoring of therapy. Ligands for somatostatin receptors are of particular interest in pituitary adenomas and meningiomas. Tracers to image neovascularization, hypoxia, and phospholipid synthesis are under investigation for potential clinical use. All methods provide the maximum of information when used with image registration and fusion display with contrast-enhanced magnetic resonance imaging scans. Integration of PET and magnetic resonance imaging with stereotactic neuronavigation systems allows the targeting of stereotactic biopsies to obtain a more accurate histologic diagnosis and better planning of conformal and stereotactic radiotherapy.
Karl Herholz; Karl-Josef Langen; Christiaan Schiepers; James M Mountz
Related Documents :
6867309 - Clinical usefulness of ct scanning in the diagnosis and treatment of lumbar spine disease.
24251759 - Serial ct findings of a rapidly calcified epidural hematoma in a young adult: a case re...
23799199 - Altered brain morphometry in carpal tunnel syndrome is associated with median nerve pat...
22987999 - The role of fdg-pet and bone marrow examination in lymphoma staging.
25086939 - Presurgical planning for hepatobiliary malignancies: clinical and imaging considerations.
23074389 - Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evi...
11145359 - Effects of head and body position on two- and three-dimensional configurations of the u...
12674239 - Computerized scheme for determination of the likelihood measure of malignancy for pulmo...
2216589 - Mr imaging of pancreas in cystic fibrosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in nuclear medicine     Volume:  42     ISSN:  1558-4623     ISO Abbreviation:  Semin Nucl Med     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-02     Completed Date:  2013-04-04     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  1264464     Medline TA:  Semin Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  356-70     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Neoplasms* / complications,  diagnosis,  pathology,  therapy
Nuclear Medicine
Opportunistic Infections
Radiopharmaceuticals / diagnostic use
Treatment Outcome
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessing spatial uncertainties of land allocation using a scenario approach and sensitivity analysi...
Next Document:  Advances in the diagnosis and treatment of epilepsy.